| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |